[Prevention of immunosuppressive action of methotrexate during chemotherapy of experimental neoplasms].
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D004336:Drug Antagonism; D005492:Folic Acid / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000037:antagonists & inhibitors*; D008727:Methotrexate / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D005492:Folic Acid; D008727:Methotrexate
Predotvrashchenie immunodepressivnogo deĭstviia metotreksata pri khimioterapii eksperimental'nykh opukholeĭ